Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Guided Therapeutics (GTHP) Shares Outstanding (2016 - 2025)

Guided Therapeutics' Shares Outstanding history spans 16 years, with the latest figure at $86.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 32.28% to $86.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $86.2 million, a 32.28% increase, with the full-year FY2025 number at $86.2 million, up 32.28% from a year prior.
  • Shares Outstanding hit $86.2 million in Q4 2025 for Guided Therapeutics, up from $83.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for GTHP hit a ceiling of $86.2 million in Q4 2025 and a floor of $1000.0 in Q2 2022.
  • Historically, Shares Outstanding has averaged $31.5 million across 5 years, with a median of $22.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding: tumbled 100.0% in 2023 and later soared 7796700.0% in 2025.
  • Tracing GTHP's Shares Outstanding over 5 years: stood at $13.7 million in 2021, then skyrocketed by 255.41% to $48.6 million in 2022, then rose by 11.34% to $54.1 million in 2023, then rose by 20.38% to $65.1 million in 2024, then skyrocketed by 32.28% to $86.2 million in 2025.
  • Business Quant data shows Shares Outstanding for GTHP at $86.2 million in Q4 2025, $83.6 million in Q3 2025, and $1.0 in Q2 2025.